NICE issues positive final guidance for INVOKANA®
Janssen has welcomed the publication of Final Guidance from the National Institute for Health and Care Excellence for canagliflozin. (Source: Pharmacy Europe)
Source: Pharmacy Europe - June 26, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Diabetes Canagliflozin Invokana janssen Latest News nice type 2 diabetes Source Type: news
SIVEXTRO™ approved to treat serious skin infections
Cubist Pharmaceuticals, Inc. has announced that the US Food and Drug Administration approved SIVEXTRO™ (tedizolid phosphate) for the treatment of adult acute bacterial skin and skin structure infections. (Source: Pharmacy Europe)
Source: Pharmacy Europe - June 26, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Dermatology approval Latest News mrsa SIVEXTRO skin infection Source Type: news
New Stelara data in psoriatic arthritis
Data has been released that support the recent label enhancement for Stelara in reducing the rate of progression of structural damage, which represents an important milestone for people living with psoriatic arthritis. (Source: Pharmacy Europe)
Source: Pharmacy Europe - June 23, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Dermatology eular Latest News psoriatic arthritis stelara Source Type: news
All-party Parliamentary Group on Cancer responds to one-year cancer survival figures
NHS England presented, for the first time within the Clinical Commissioning Group (CCG) Outcomes Indicator Set (a key tool in monitoring CCGs’ progress), local one-year survival figures for all cancers in England. (Source: Pharmacy Europe)
Source: Pharmacy Europe - June 19, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Guidelines All-party Parliamentary Group on Cancer Clinical Commissioning Group Outcomes Indicator Set Latest News Source Type: news
New approach to accelerate dementias research
The Medical Research Council has today launched the UK Dementias Research Platform, a £16 million public–private partnership set up to speed up research into dementias. (Source: Pharmacy Europe)
Source: Pharmacy Europe - June 19, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Neurology dementia Latest News mrc pharmaceutical industry UK Dementias Research Platform UKDP Source Type: news
Gardasil® HPV vaccine approved for the prevention of anal cancer
Sanofi Pasteur MSD announced today that the European Commission has granted marketing authorisation for the use of Gardasil® (human papillomavirus vaccine [types 6, 11, 16, 18] [recombinant, adsorbed]) for the prevention of anal precancerous lesions and anal cancers causally related to certain oncogenic human papillomavirus types in both males and females. (Source: Pharmacy Europe)
Source: Pharmacy Europe - June 19, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Oncology anal cancer gardasil hpv human papillomavirus Latest News Sanofi Pasteur MSD Source Type: news
AMITIZA® (lubiprostone) receives NICE recommendation
Sucampo Pharmaceuticals, Inc., has announced that the NICE has released a Final Appraisal Determination with guidance for the recommendation of the use of AMITIZA® (lubiprostone) in the treatment of chronic idiopathic constipation and associated symptoms in adults who have failed laxatives. (Source: Pharmacy Europe)
Source: Pharmacy Europe - June 19, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Gastroenterology amitiza chronic idiopathic constipation Inc. Latest News lubiprostone Sucampo Pharmaceuticals Source Type: news
Wet AMD drug changed by Italy government
Dr Steven Bradshaw, a drug policy expert and former ophthalmologist, is disappointed at the news of the Italian government’s decision to substitute wet age-related macular degeneration treatment drug, from Lucentis to Roche’s Avastin. (Source: Pharmacy Europe)
Source: Pharmacy Europe - June 16, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: Industry News avastin italy Latest News lucentis Steven Bradshaw wet age-related macular degeneration Source Type: news
Poorly soluble drugs workshop
The second APGI Poorly Soluble Drugs Workshop will be held on 2 July 2014 in Lille, France. (Source: Pharmacy Europe)
Source: Pharmacy Europe - June 16, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: European Conferences and Symposia AGPI Association de Pharmacie Galénique Industirelle International Society of Drug Delivery Sciences and Technology Latest News Poorly soluble drugs workshop Source Type: news
Significant results for polycythemia vera patients on Jakavi®
Novartis has announced results from the first-ever pivotal Phase III study evaluating a JAK 1/2 inhibitor for the treatment of polycythemia vera (PV). (Source: Pharmacy Europe)
Source: Pharmacy Europe - June 16, 2014 Category: Drugs & Pharmacology Authors: ebercott Tags: *** Editor's Pick Oncology Latest News Source Type: news
Building a better world for people with psoriasis
At the annual World Psoriasis Day Supporters Training Meeting in Frankfurt, June 8, the International Federation of Psoriasis Associations (IFPA) announced that it is launching an online survey to help identify the tools needed to improve the lives of the more than 125 million people who have psoriasis. (Source: Pharmacy Europe)
Source: Pharmacy Europe - June 16, 2014 Category: Drugs & Pharmacology Authors: ebercott Tags: *** Editor's Pick Dermatology Latest News Source Type: news
Pan-European burden of asthma revealed
Data from the REALISE survey highlight a high incidence of recent exacerbations, even among patients whose asthma is controlled according to clinical guidelines. (Source: Pharmacy Europe)
Source: Pharmacy Europe - June 13, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: Respiratory asthma GINA Global Initiative for Asthma Latest News REALISE Source Type: news
Vaccine candidate against Chikungunya fever
A prophylactic vaccine candidate against Chikungunya fever, developed by Themis Bioscience GmbH, “induces a significant neutralising immune response and was also confirmed as safe.” (Source: Pharmacy Europe)
Source: Pharmacy Europe - June 13, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: Infectious Disease Chikungunya fever Latest News prophylactic vaccine candidate Themis Bioscience GmbH Source Type: news
Patient attitudes and adherence to treatment across six chronic inflammatory diseases
AbbVie announced results from its multi-country ALIGN study, which shows that across six chronic immune-mediated inflammatory diseases, adherence to treatment was generally higher in patients being treated with tumour necrosis factor inhibitors compared with patients treated with conventional therapy. (Source: Pharmacy Europe)
Source: Pharmacy Europe - June 12, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: Rheumatology AbbVie ALIGN chronic immune-mediated inflammatory disease Latest News tumour necrosis factor inhibitors Source Type: news
